Brain Tumors Flashcards
86 dogs w brain tumors 41 definitive Tx (Sx, Co60 3.8-4Gyx12 MWF, I125, chemo) 7 no Tx 38 symptomatic Tx All had neuro signs
OMST =
OMST = 1 mo
86 dogs w brain tumors 41 definitive Tx (Sx, Co60 3.8-4Gyx12 MWF, I125, chemo) 7 no Tx 38 symptomatic Tx All had neuro signs
MST w Sx =
MST w Sx = 1 mo
86 dogs w brain tumors 41 definitive Tx (Sx, Co60 3.8-4Gyx12 MWF, I125, chemo) 7 no Tx 38 symptomatic Tx All had neuro signs
MST w RT =
MST w RT = 5 mo
86 dogs w brain tumors 41 definitive Tx (Sx, Co60 3.8-4Gyx12 MWF, I125, chemo) 7 no Tx 38 symptomatic Tx All had neuro signs
MST w medical management =
MST w medical management = 2 weeks
86 dogs w brain tumors 41 definitive Tx (Sx, Co60 3.8-4Gyx12 MWF, I125, chemo) 7 no Tx 38 symptomatic Tx All had neuro signs
3 positive prognostic factors =
Less neurological signs
Solitary tumor
RT treatment
14 dogs w brian masses
4 meningiomas, 1 LSA, 1 pituitary tumor
Orthovoltage
9 39Gy RT, 5 45 Gy RT
OMST =
OMST = 16 mo
14 dogs w brian masses
4 meningiomas, 1 LSA, 1 pituitary tumor
Orthovoltage
9 39Gy RT, 5 45 Gy RT
MST w 39Gy total =
MST w 39Gy total = 5 mo
14 dogs w brian masses
4 meningiomas, 1 LSA, 1 pituitary tumor
Orthovoltage
9 39Gy RT, 5 45 Gy RT
MST w 45Gy total =
MST w 45Gy total = 17 mo
14 dogs w brian masses
4 meningiomas, 1 LSA, 1 pituitary tumor
Orthovoltage
9 39Gy RT, 5 45 Gy RT
What’s the technique to overcome skin SE?
3 fields technique
83 dogs w brain masses
38Gy total RT w megavoltage manual plans
5, 7, 8, 9, 9 Gy q1w (dose escalating plan)
OMST =
OMST = 11 mo
83 dogs w brain masses
38Gy total RT w megavoltage manual plans
5, 7, 8, 9, 9 Gy q1w (dose escalating plan)
MST in extra-axial tumor =
MST in extra-axial tumor = 12.4 mo
83 dogs w brain masses
38Gy total RT w megavoltage manual plans
5, 7, 8, 9, 9 Gy q1w (dose escalating plan)
MST in intra-axial tumor =
MST in intra-axial tumor = 10 mo
83 dogs w brain masses
38Gy total RT w megavoltage manual plans
5, 7, 8, 9, 9 Gy q1w (dose escalating plan)
MST in pituitary tumor =
MST in pituitary tumor = 5 mo
83 dogs w brain masses
38Gy total RT w megavoltage manual plans
5, 7, 8, 9, 9 Gy q1w (dose escalating plan)
___ dogs died d/t deterioration ____ days post RT
2 dogs
2-3 days
83 dogs w brain masses
38Gy total RT w megavoltage manual plans
5, 7, 8, 9, 9 Gy q1w (dose escalating plan)
___ % died of late SE (brain nectosis)
14%
83 dogs w brain masses
38Gy total RT w megavoltage manual plans
5, 7, 8, 9, 9 Gy q1w (dose escalating plan)
RT necrosis: severe rapid neuro decline over ____ days; focal necrosis & hemorrhage 2ndary to ____
2-5 days
vascular endothelial prolifeartion
29 dogs w intracranial masses
22 meningiomas, 4 gliomas, 3 choroid plexus
Co-60, 48Gy (3Gy x 16, M-F)
Whole brain target
MST =
MST = 8 mo
29 dogs w intracranial masses
22 meningiomas, 4 gliomas, 3 choroid plexus
Co-60, 48Gy (3Gy x 16, M-F)
Whole brain target
_____ dogs died d/t PD during RT
2 dogs died
29 dogs w intracranial masses
22 meningiomas, 4 gliomas, 3 choroid plexus
Co-60, 48Gy (3Gy x 16, M-F)
Whole brain target
_____ % died d/t PD/recurrence
76%
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
OPFS =
OPFS = 30 mo
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
PF (proliferative fraction) PCNA = %
PF PCNA = 24%
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
Progesterone receptor = ______ %
Progesterone R = 70%
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
Estrogen receptor = ______ %
Estrogens R = 0%
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
PF PCNA & progesterone ____________ correlated
PF PCNA & progesterone inversely correlated
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
OPFS 2 years = _______ %
OPFS 2 years = 68%
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
Prognostic factor of PFS =
PF PCNA
20 dogs w meningioma
Incomplete Sx + Co60 (4Gy x 12= 48Gy)
2 years PFS w PF PCNA > 24% =
42%